Cosmo Bio Company,Limited
JPX: 3386.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Norihiko Shibayama
- Employees
- 174
- Headquarters
- Tokyo, Japan
- IPO year
- 2005
- Market cap
- ¥7.2B
- Website
- https://www.cosmobio.co.jp
Loading 3386…
Loading profile data…Frequently asked questions about 3386
What does Cosmo Bio Company,Limited (3386.T) do?
Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools. Its life science research tools include reagents, kits, instruments, software, and diagnostics products. The company offers research reagents, such as antibodies, antigens, biologically active substances, enzymes, substrat...
Where does 3386.T trade?
Cosmo Bio Company,Limited (3386.T) trades on the Tokyo Stock Exchange.
What sector is 3386.T in?
Cosmo Bio Company,Limited (3386.T) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Cosmo Bio Company,Limited?
Norihiko Shibayama is the chief executive officer of Cosmo Bio Company,Limited (3386.T).
Where is Cosmo Bio Company,Limited headquartered?
Cosmo Bio Company,Limited is headquartered in Japan.
Does 3386.T pay a dividend?
Yes — Cosmo Bio Company,Limited (3386.T) paid a trailing twelve-month dividend of JPY 50.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3386.T go public?
Cosmo Bio Company,Limited (3386.T) completed its initial public offering in 2005.